Email Alert RSS
Volume 13 Issue 5
Sep.  2022
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2022  >  13(5): 753-759
LI Xiaoyan, XU Xinjie, LUO Xin, YOU Xin. Research Progress in the Treatment of Autism Spectrum Disorder with Fecal Microbiota Transplantation[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 753-759. doi: 10.12290/xhyxzz.2022-0301
Citation: LI Xiaoyan, XU Xinjie, LUO Xin, YOU Xin. Research Progress in the Treatment of Autism Spectrum Disorder with Fecal Microbiota Transplantation[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 753-759. doi: 10.12290/xhyxzz.2022-0301
shu

Research Progress in the Treatment of Autism Spectrum Disorder with Fecal Microbiota Transplantation

doi: 10.12290/xhyxzz.2022-0301
  • 1.

    Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds:

CAMS Innovation Fund for Medical Sciences 2017-I2M-3-017

Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2019XK320030

More Information
  • Corresponding author: YOU Xin, E-mail: youxin@pumch.cn
  • Received Date: 2022-05-30
  • Accepted Date: 2022-07-28
    • Available Online: 2022-08-12
  • Publish Date: 2022-09-30
    Abstract
  • Autism spectrum disorder (ASD), a neurodevelopmental disorder during early childhood, currently has no effective treatment. The prevalence of ASD has been increasing, which brings a heavy burden to the family of the patients and the society. Children with ASD are accompanied by gastrointestinal symptoms and have an imbalance of intestinal microbiota. Fecal microbiota transplantation (FMT) can improve autism-related symptoms in children with ASD. This review aims to summarize the research progress of FMT for treating ASD to provide a novel strategy for this untreatable disease.
    • FullText(HTML)
  • loading
    • References(59)
  • [1] American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5[M]. 5th ed. Washington DC: American Psychiatric Association, 2013: 50-59.
    [2] Maenner MJ, Shaw KA, Bakian AV, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years-Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018[J]. MMWR Surveill Summ, 2021, 70: 336-346.
    [3] Sun X, Allison C, Matthews FE, et al. Exploring the Underdiagnosis and Prevalence of Autism Spectrum Conditions in Beijing[J]. Autism Res, 2015, 8: 250-260. doi:  10.1002/aur.1441
    [4] Roberts EM, English PB, Grether JK, et al. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley[J]. Environ Health Perspect, 2007, 115: 1482-1489. doi:  10.1289/ehp.10168
    [5] Karimi P, Kamali E, Mousavi SM, et al. Environmental factors influencing the risk of autism[J]. J Res Med Sci, 2017, 22: 27. doi:  10.4103/1735-1995.200272
    [6] Lord C, Elsabbagh M, Baird G, et al. Autism spectrum disorder[J]. Lancet, 2018, 392: 508-520. doi:  10.1016/S0140-6736(18)31129-2
    [7] Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder[J]. Nat Rev Dis Primers, 2020, 6: 5. doi:  10.1038/s41572-019-0138-4
    [8] Yu Y, Zhang B, Ji P, et al. Changes to gut amino acid transporters and microbiome associated with increased E/I ratio in Chd8 mouse model of ASD-like behavior[J]. Nat Commun, 2022, 13: 1151. doi:  10.1038/s41467-022-28746-2
    [9] Mannion A, Leader G. Gastrointestinal Symptoms in Autism Spectrum Disorder: A Literature Review[J]. Rev J Autism Dev Disord, 2013, 1: 11-17.
    [10] Buie T, Campbell DB, Fuchs GJ, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report[J]. Pediatrics, 2010, 125: S1-S18. doi:  10.1542/peds.2009-1878C
    [11] Restrepo B, Angkustsiri K, Taylor SL, et al. Developmental- behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms[J]. Autism Res, 2020, 13: 1778-1789. doi:  10.1002/aur.2354
    [12] Srikantha P, Mohajeri MH. The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder[J]. Int J Mol Sci, 2019, 20: 2115. doi:  10.3390/ijms20092115
    [13] Stewart CJ, Ajami NJ, O'Brien JL, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study[J]. Nature, 2018, 562: 583-588. doi:  10.1038/s41586-018-0617-x
    [14] Tamburini S, Shen N, Wu HC, et al. The microbiome in early life: implications for health outcomes[J]. Nat Med, 2016, 22: 713-722. doi:  10.1038/nm.4142
    [15] Sharon G, Sampson TR, Geschwind DH, et al. The Central Nervous System and the Gut Microbiome[J]. Cell, 2016, 167: 915-932. doi:  10.1016/j.cell.2016.10.027
    [16] Planer JD, Peng Y, Kau AL, et al. Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice[J]. Nature, 2016, 534: 263-266. doi:  10.1038/nature17940
    [17] Lou M, Cao A, Jin C, et al. Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder[J]. Gut, 2022, 71: 1588-1599.
    [18] Blanton LV, Charbonneau MR, Salih T, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children[J]. Science, 2016, 351: 10.1126/science.aad3311 aad3311.
    [19] Strati F, Cavalieri D, Albanese D, et al. New evidences on the altered gut microbiota in autism spectrum disorders[J]. Microbiome, 2017, 5: 24. doi:  10.1186/s40168-017-0242-1
    [20] Dan Z, Mao X, Liu Q, et al. Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder[J]. Gut Microbes, 2020, 11: 1246-1267. doi:  10.1080/19490976.2020.1747329
    [21] Iglesias-Vázquez L, Van Ginkel Riba G, Arija V, et al. Composition of Gut Microbiota in Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis[J]. Nutrients, 2020, 12: 792. doi:  10.3390/nu12030792
    [22] Kandeel WA, Meguid NA, Bjørklund G, et al. Impact of Clostridium Bacteria in Children with Autism Spectrum Disorder and Their Anthropometric Measurements[J]. J Mol Neurosci, 2020, 70: 897-907. doi:  10.1007/s12031-020-01482-2
    [23] Wang L, Christophersen CT, Sorich MJ, et al. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder[J]. Mol Autism, 2013, 4: 42. doi:  10.1186/2040-2392-4-42
    [24] Liu S, Li E, Sun Z, et al. Altered gut microbiora and short chain fatty acids in Chinese children with autism spectrum disorder[J]. Sci Rep, 2019, 9: 287. doi:  10.1038/s41598-018-36430-z
    [25] Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function[J]. Aliment Pharmacol Ther, 2008, 27: 104-119.
    [26] Tomova A, Husarova V, Lakatosova S, et al. Gastrointestinal microbiota in children with autism in Slovakia[J]. Physiol Behav, 2015, 138: 179-187. doi:  10.1016/j.physbeh.2014.10.033
    [27] Adams JB, Johansen LJ, Powell LD, et al. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity[J]. BMC Gastroenterol, 2011, 11: 22. doi:  10.1186/1471-230X-11-22
    [28] Kang DW, Ilhan ZE, Isern NG, et al. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders[J]. Anaerobe, 2018, 49: 121-131. doi:  10.1016/j.anaerobe.2017.12.007
    [29] Luna RA, Oezguen N, Balderas M, et al. Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder[J]. Cell Mol Gastroenterol Hepatol, 2017, 3: 218-230. doi:  10.1016/j.jcmgh.2016.11.008
    [30] Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations[J]. Cell, 2021, 184: 5916-5931. doi:  10.1016/j.cell.2021.10.015
    [31] Akins RS, Angkustsiri K, Hansen RL. Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families[J]. Neurotherapeutics, 2010, 7: 307-319. doi:  10.1016/j.nurt.2010.05.002
    [32] Anon. The brain-gut axis: a new frontier. Proceedings of an international symposium. Florence Italy, June 29-July 1, 1981[J]. Peptides, 1981, 2: 1-299.
    [33] Bove C, Travagli RA. Neurophysiology of the brain stem in Parkinson's disease[J]. J Neurophysiol, 2019, 121: 1856-1864. doi:  10.1152/jn.00056.2019
    [34] Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota- Gut-Brain Axis[J]. Physiol Rev, 2019, 99: 1877-2013. doi:  10.1152/physrev.00018.2018
    [35] Margolis KG, Cryan JF, Mayer EA. The Microbiota-Gut-Brain Axis: From Motility to Mood[J]. Gastroenterology, 2021, 160: 1486-1501. doi:  10.1053/j.gastro.2020.10.066
    [36] Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour[J]. Nat Rev Neurosci, 2012, 13: 701-712. doi:  10.1038/nrn3346
    [37] Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous entero-colitis[J]. Surgery, 1958, 44: 854-859.
    [38] Kelly CR, Fischer M, Allegretti JR, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections[J]. Am J Gastroenterol, 2021, 116: 1124-1147. doi:  10.14309/ajg.0000000000001278
    [39] Haifer C, Paramsothy S, Kaakoush NO, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial[J]. Lancet Gastroenterol Hepatol, 2022, 7: 141-151. doi:  10.1016/S2468-1253(21)00400-3
    [40] Holvoet T, Joossens M, Vázquez-Castellanos JF, et al. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short-and Long-term Results From a Placebo-Controlled Randomized Trial[J]. Gastroenterology, 2021, 160: 145-157. doi:  10.1053/j.gastro.2020.07.013
    [41] Kim MS, Kim Y, Choi H, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model[J]. Gut, 2020, 69: 283-294. doi:  10.1136/gutjnl-2018-317431
    [42] Hazan S. Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report[J]. J Int Med Res, 2020, 48: 300060520925930.
    [43] Xiao L, Yan J, Yang T, et al. Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice[J]. MSystems, 2021, 6: e01343-20.
    [44] Sharon G, Cruz NJ, Kang DW, et al. Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice[J]. Cell, 2019, 177: 1600-1618. doi:  10.1016/j.cell.2019.05.004
    [45] Goo N, Bae HJ, Park K, et al. The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice[J]. Life Sci, 2020, 262: 118497. doi:  10.1016/j.lfs.2020.118497
    [46] Li Y, Luo ZY, Hu YY, et al. The gut microbiota regulates autism-like behavior by mediating vitamin B homeostasis in EphB6-deficient mice[J]. Microbiome, 2020, 8: 120. doi:  10.1186/s40168-020-00884-z
    [47] Kang DW, Adams JB, Gregory AC, et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study[J]. Microbiome, 2017, 5: 10. doi:  10.1186/s40168-016-0225-7
    [48] Kang DW, Adams JB, Coleman DM, et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota[J]. Sci Rep, 2019, 9: 5821. doi:  10.1038/s41598-019-42183-0
    [49] Li N, Chen H, Cheng Y, et al. Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study[J]. Front Cell Infect Microbiol, 2021, 11: 759435. doi:  10.3389/fcimb.2021.759435
    [50] Kang DW, Adams JB, Vargason T, et al. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy[J]. mSphere, 2020, 5: e00314-20.
    [51] Qureshi F, Adams J, Hanagan K, et al. Multivariate Analysis of Fecal Metabolites from Children with Autism Spectrum Disorder and Gastrointestinal Symptoms before and after Microbiota Transfer Therapy[J]. J Pers Med, 2020, 10: 152. doi:  10.3390/jpm10040152
    [52] Ye C, Zhang XY, Cui JQ, et al. FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder[J]. BMJ Open, 2022, 12: e051613. doi:  10.1136/bmjopen-2021-051613
    [53] Tariq R, Pardi DS, Bartlett MG, et al. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis[J]. Clin Infect Dis, 2019, 68: 1351-1358. doi:  10.1093/cid/ciy721
    [54] Fecal Microbiota Transplantation-standardization Study Group. Nanjing consensus on methodology of washed microbiota transplantation[J]. Chin Med J, 2020, 133: 2330-2332. doi:  10.1097/CM9.0000000000000954
    [55] Aggarwala V, Mogno I, Li Z, et al. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes[J]. Nat Microbiol, 2021, 6: 1309-1318. doi:  10.1038/s41564-021-00966-0
    [56] Haifer C, Saikal A, Paramsothy R, et al. Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy[J]. Gut, 2021, 70: 2210-2211. doi:  10.1136/gutjnl-2020-323581
    [57] DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant Bacteremia Transmitted by Fecal Microbiota Transplant[J]. N Engl J Med, 2019, 381: 2043-2050. doi:  10.1056/NEJMoa1910437
    [58] Marcella C, Cui B, Kelly CR, et al. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020[J]. Aliment Pharmacol Ther, 2021, 53: 33-42.
    [59] Papanicolas LE, Gordon DL, Wesselingh SL, et al. Improv-ing Risk-Benefit in Faecal Transplantation through Microbiome Screening[J]. Trends Microbiol, 2020, 28: 331-339. doi:  10.1016/j.tim.2019.12.009
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3152) PDF downloads(239) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return